Pharmacological undertreatment of coronary risk factors in patients with psoriasis: Observational study of the danish nationwide registries

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Ahlehoff, Ole ^a,b   Skov, Lone ^a   Gislason, Gunnar ^a   Lindhardsen, Jesper ^a   Kristensen, Søren Lund ^a   Iversen, Lars ^c   Lasthein, Stine ^d   Gniadecki, Robert ^e   Dam, Tomas Norman ^b   Torp Pedersen, Christian ^a   Hansen, Peter Riis ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EFALIZUMAB; ETANERCEPT; INFLIXIMAB; LOOP DIURETIC AGENT; METHOTREXATE; PSORALEN; RETINOID DERIVATIVE; THIAZIDE DIURETIC AGENT; TOCILIZUMAB; USTEKINUMAB;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK FACTOR; DENMARK; DIABETES MELLITUS; DISEASE REGISTRY; DISEASE SEVERITY; DRUG THERAPY; DRUG USE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT INFORMATION; PSORIASIS; SOCIAL STATUS; CORONARY ARTERY DISEASE; MIDDLE AGED; REGISTER; RISK FACTOR;

CORONARY DISEASE; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; REGISTRIES; RISK FACTORS;

EID: 84860431562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036342     Document Type: Article

References (26)

1. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA, (2007) Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 190: 1-9.
2. Azfar RS, Gelfand JM, (2008) Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 20: 416-422.
3. Menter A, Griffiths C, Tebbey P, Horn E, Sterry W, (2010) Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol 24: 1371-1377.
4. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296: 1735-1741.
5. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, et al. (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31: 1000-1006.
6. Ahlehoff O, Gislason GH, Charlot M, Jorgensen CH, Lindhardsen J, et al. (2011) Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 270: 147-157.
7. Ahlehoff O, Gislason GH, Jorgensen CH, Lindhardsen J, Charlot M, et al. (2011) Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J Aug 25 [Epub ahead of print].
8. Wenger NS, Solomon DH, Roth CP, MacLean CH, Saliba D, et al. (2003) The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med 139: 740-747.
9. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, et al. (2000) Quality of care for patients with rheumatoid arthritis. JAMA 284: 984-992.
10. Parsi KK, Brezinski EA, Lin TC, Li CS, Armstrong AW, (2011) Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists. J Am Acad Dermatol Nov 12 [Epub ahead of print].
11. Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, et al. (2011) Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol Oct 21 [Epub ahead of print].
12. Gniadecki R, Kragballe K, Dam TN, Skov L, (2011) Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris. Br J Dermatol 164: 1091-1096.
13. Malik S, Lopez V, Chen R, Wu W, Wong ND, (2007) Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Res Clin Pract 77: 126-133.
14. Zafrir B, Cohen S, (2006) Primary prevention in high-risk dyslipidemic patients without an established cardiovascular disease: Undertreatment and rationale for lipid-lowering therapy. Eur J Intern Med 17: 495-499.
15. Kones R, (2011) Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Ther Adv Cardiovasc Dis 5: 61-81.
16. Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, et al. (2008) AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 102: 1631-1643.
17. Gisondi P, Farina S, Giordano MV, Girolomoni G, (2010) Usefulness of the Framingham Risk Score in Patients With Chronic Psoriasis. Am J Cardiol 106: 1754-1757.
18. Rapport udvalg nedsat af DDS DCS og DRS (2010) Anbefalinger for vurdering af risiko for kardiovaskulær sygdom hos patienter med psoriasis og psoriasis artrit.
19. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69: 325-331.
20. Basavaraj KH, Ashok NM, Rashmi R, Praveen TK, The role of drugs in the induction and/or exacerbation of psoriasis. Int J Dermatol 49: 1351-1361.
21. Ahlehoff O, Gislason GH, Lindhardsen J, Olesen JB, Charlot M, et al. (2011) Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study. J Intern Med 270: 237-244.
22. Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, et al. (2008) National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 58: 1031-1042.
23. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, et al. (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis and rheumatism 44: 2331-2337.
24. Balci DD, Balci A, Karazincir S, Ucar E, Iyigun U, et al. (2009) Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 23: 1-6.
25. Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, et al. (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156: 271-276.
26. De Simone C, Di Giorgio A, Sisto T, Carbone A, Ghitti F, et al. Endothelial dysfunction in psoriasis patients: cross-sectional case-control study. Eur J Dermatol 21: 510-514.